PT1910839T - Gene tom34 relacionado com o cancro do cólon - Google Patents

Gene tom34 relacionado com o cancro do cólon

Info

Publication number
PT1910839T
PT1910839T PT67818575T PT06781857T PT1910839T PT 1910839 T PT1910839 T PT 1910839T PT 67818575 T PT67818575 T PT 67818575T PT 06781857 T PT06781857 T PT 06781857T PT 1910839 T PT1910839 T PT 1910839T
Authority
PT
Portugal
Prior art keywords
tom34
gene
colon cancer
colon
cancer
Prior art date
Application number
PT67818575T
Other languages
English (en)
Portuguese (pt)
Inventor
Tahara Hideaki
Nakamura Yusuke
Tsunoda Takuya
Furukawa Yoichi
Matsushima Satoshi
Original Assignee
Oncotherapy Science Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncotherapy Science Inc filed Critical Oncotherapy Science Inc
Publication of PT1910839T publication Critical patent/PT1910839T/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57535Immunoassay; Biospecific binding assay; Materials therefor for cancer of the large intestine, e.g. colon, rectum or anus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3046Stomach, Intestines
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/136Screening for pharmacological compounds
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT67818575T 2005-07-27 2006-07-21 Gene tom34 relacionado com o cancro do cólon PT1910839T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70326505P 2005-07-27 2005-07-27

Publications (1)

Publication Number Publication Date
PT1910839T true PT1910839T (pt) 2016-07-14

Family

ID=37499354

Family Applications (1)

Application Number Title Priority Date Filing Date
PT67818575T PT1910839T (pt) 2005-07-27 2006-07-21 Gene tom34 relacionado com o cancro do cólon

Country Status (18)

Country Link
US (1) US8674059B2 (https=)
EP (1) EP1910839B1 (https=)
JP (2) JP5095603B2 (https=)
KR (2) KR101325194B1 (https=)
CN (1) CN101278196B (https=)
AU (1) AU2006273192B2 (https=)
BR (1) BRPI0613970B8 (https=)
CA (1) CA2616497C (https=)
CY (1) CY1117839T1 (https=)
DK (1) DK1910839T3 (https=)
ES (1) ES2584247T3 (https=)
HU (1) HUE027330T2 (https=)
PL (1) PL1910839T3 (https=)
PT (1) PT1910839T (https=)
RU (2) RU2449020C2 (https=)
SG (1) SG163614A1 (https=)
SI (1) SI1910839T1 (https=)
WO (1) WO2007013576A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102439147A (zh) * 2009-03-04 2012-05-02 肿瘤疗法科学股份有限公司 Vangl1肽及包含它们的疫苗
TWI485245B (zh) * 2010-01-25 2015-05-21 Oncotherapy Science Inc 經修飾之melk胜肽及含此胜肽之疫苗
TW201211250A (en) * 2010-09-07 2012-03-16 Oncotherapy Science Inc VANGL1 peptides and vaccines including the same
SG190407A1 (en) * 2010-12-02 2013-06-28 Oncotherapy Science Inc Tomm34 peptides and vaccines including the same
KR102127211B1 (ko) 2011-10-28 2020-06-29 온코세라피 사이언스 가부시키가이샤 Topk 펩티드 및 이를 포함하는 백신
SG11201405578TA (en) 2012-03-09 2014-11-27 Oncotherapy Science Inc Pharmaceutical composition containing peptide
EP3187191B1 (en) * 2014-08-26 2020-04-08 NKMAX Co., Ltd. Antibody for recognizing specific motif of wls protein, and pharmaceutical composition containing same

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4722848A (en) 1982-12-08 1988-02-02 Health Research, Incorporated Method for immunizing animals with synthetically modified vaccinia virus
US5785973A (en) * 1988-02-01 1998-07-28 Praxis Biologics, Inc. Synthetic peptides representing a T-cell epitope as a carrier molecule for conjugate vaccines
JPH04504416A (ja) * 1989-02-17 1992-08-06 コセルコ・ミモトープス・ピィ・ティ・ワイ.エル・ティ・ディ. ペプチドの使用方法と合成方法
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5804566A (en) 1993-08-26 1998-09-08 The Regents Of The University Of California Methods and devices for immunizing a host through administration of naked polynucleotides with encode allergenic peptides
US5679647A (en) 1993-08-26 1997-10-21 The Regents Of The University Of California Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides
US5739118A (en) 1994-04-01 1998-04-14 Apollon, Inc. Compositions and methods for delivery of genetic material
US5736524A (en) 1994-11-14 1998-04-07 Merck & Co.,. Inc. Polynucleotide tuberculosis vaccine
US5922687A (en) 1995-05-04 1999-07-13 Board Of Trustees Of The Leland Stanford Junior University Intracellular delivery of nucleic acids using pressure
US20030198642A1 (en) 1995-08-03 2003-10-23 Johannes J. Geuze Cell derived antigen presenting vesicles
US5840839A (en) * 1996-02-09 1998-11-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein
US5853719A (en) 1996-04-30 1998-12-29 Duke University Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
EP0960204A4 (en) 1996-07-26 2002-01-23 Sloan Kettering Inst Cancer METHODS AND REAGENTS FOR GENETIC IMMUNIZATION
FR2766205B1 (fr) 1997-07-16 2002-08-30 Inst Nat Sante Rech Med Nouveau procede de sensibilisation de cellules presentatrices d'antigene et nouveaux moyens pour la mise en oeuvre du procede
US7166573B1 (en) * 1999-05-28 2007-01-23 Ludwig Institute For Cancer Research Breast, gastric and prostate cancer associated antigens and uses therefor
EP1250145A4 (en) 2000-01-03 2003-03-26 Argonex Pharmaceuticals Inc PEPTIDES DERIVED FROM ONCOGENE C-SKI FOR THE PREVENTION, TREATMENT AND DIAGNOSIS OF CANCER
US7700359B2 (en) * 2000-06-02 2010-04-20 Novartis Vaccines And Diagnostics, Inc. Gene products differentially expressed in cancerous cells
US20040181344A1 (en) * 2002-01-29 2004-09-16 Massachusetts Institute Of Technology Systems and methods for providing diagnostic services
TW200413406A (en) 2002-08-26 2004-08-01 Kirin Brewery Peptides and drugs containing the same
PT1581812E (pt) 2003-01-06 2008-09-22 Wyeth Corp Composições e métodos para diagnóstico e tratamento de cancros do cólon

Also Published As

Publication number Publication date
KR20080040738A (ko) 2008-05-08
JP5095603B2 (ja) 2012-12-12
KR20130087639A (ko) 2013-08-06
US8674059B2 (en) 2014-03-18
HK1115193A1 (zh) 2008-11-21
SG163614A1 (en) 2010-08-30
BRPI0613970B1 (pt) 2019-10-29
ES2584247T3 (es) 2016-09-26
SI1910839T1 (sl) 2016-06-30
CN101278196A (zh) 2008-10-01
JP2012125248A (ja) 2012-07-05
RU2008107318A (ru) 2009-09-10
EP1910839B1 (en) 2016-04-27
WO2007013576A1 (en) 2007-02-01
KR101325194B1 (ko) 2013-11-06
AU2006273192B2 (en) 2011-09-01
CA2616497C (en) 2016-06-07
AU2006273192A1 (en) 2007-02-01
CN101278196B (zh) 2013-05-15
EP1910839A1 (en) 2008-04-16
BRPI0613970B8 (pt) 2021-05-25
RU2449020C2 (ru) 2012-04-27
BRPI0613970A2 (pt) 2011-02-22
HUE027330T2 (en) 2016-09-28
US20090214571A1 (en) 2009-08-27
RU2011127868A (ru) 2013-01-20
PL1910839T3 (pl) 2016-11-30
RU2526196C2 (ru) 2014-08-20
CA2616497A1 (en) 2007-02-01
CY1117839T1 (el) 2017-05-17
DK1910839T3 (en) 2016-07-04
JP2009502732A (ja) 2009-01-29

Similar Documents

Publication Publication Date Title
DK2115472T3 (da) Cancerbiomarkører
BRPI0718796A2 (pt) Nucleotídeo
DE602006019691D1 (de) Polycarbonatdiol
IL227562A (en) Markers for breast cancer
DE602006000573D1 (de) Gleitelement
DK1931713T3 (da) Aryl-/alkylravsyreanhydridhyaluronderivater
EP2212435A4 (en) FUSIONED GENE BZW. FUSIONED GENES
FR2904920B1 (fr) Attache
DE602005027253D1 (de) Herbizidresistenz verleihende gene
DE602006013094D1 (de) Krebsmittel
PT1910839T (pt) Gene tom34 relacionado com o cancro do cólon
KR100631079B9 (ko) 부양식 분수대
EP1937503A4 (en) DIFFERENTIAL
ITMI20051226A1 (it) Cassa continua
FI20065168L (fi) Tulisija
ES1063822Y (es) Maleta mejorada
UA12596S (uk) Комплект наличок
ITVR20060177A1 (it) Valigia portapeso
ES1060992Y (es) Un cuaderno
ITTN20050009U1 (it) Tavoletta natatoria galleggiante modificata
ES1060537Y (es) Boligrafo
ES1064201Y (es) Bolso
TH84210B (th) ปากกา
TH84211B (th) ปากกา
TH86315B (th) ปากกา